4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-077706
Chief Technical Officer sold 3,984 shares at $90.08 ($358,891)
- Chief Technical Officer acquired 3,984 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-08-11 | Option exercise 10b5-1 | +3,984 | $6.80 | $27,091 | 12,493 | D |
| Shulman Joseph Chief Technical Officer | 2025-08-11 | Sale 10b5-1 | −3,984 | $90.08 | $358,891 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-08-11 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −3,984 | 7,969 | D | ||
| Open-market sales · 3,984 sh · avg $90.08 · $358,891 | |||||||
Loading xslF345X05/tm2523328-1_4seq1.xml…